D-0098-2017 Class III Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0098-2017 was initiated by Dr. Reddy's Laboratories, Inc. on Aug 29, 2016 and is designated Class III. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Nov 8, 2019). Affected quantity: 3,858 prescription packs (115,680 capsules).

Recall details

Product Type
Drugs
Report Date
Oct 19, 2016
Initiation Date
Aug 29, 2016
Termination Date
Nov 8, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,858 prescription packs (115,680 capsules)

Product description

ZENATANE (isotretinoin capsules USP) 20 mg, 30 capsules per prescription pack, Rx Only, Manufactured by: Cipla Limited, Kurkumbh Village Pune 4138012 India, Manufactured for: Dr. Reddy's Laboratories Limited Bachupally 500 090 India, NDC 55111-136-81

Reason for recall

Failed Dissolution Specifications

Distribution pattern

nationwide

Code information

Lot # 79KB60205; Exp. 02/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0098-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0098-2017. Report a data issue: hello@regdatalab.com.